| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.873.324 | 5.209.784 | 5.400.829 | 8.199.822 | 14.333.541 | 19.054.746 | 24.105.362 | 27.381.610 | 22.975.954 | 41.038.380 |
| Total Income - EUR | 4.892.108 | 5.250.072 | 5.457.754 | 8.243.459 | 14.472.462 | 19.250.180 | 24.148.959 | 27.504.860 | 23.153.924 | 41.146.134 |
| Total Expenses - EUR | 4.879.306 | 5.122.991 | 5.409.719 | 8.076.003 | 14.194.266 | 18.914.611 | 23.960.599 | 27.294.287 | 22.811.117 | 40.315.959 |
| Gross Profit/Loss - EUR | 12.802 | 127.081 | 48.034 | 167.456 | 278.196 | 335.569 | 188.360 | 210.573 | 342.807 | 830.175 |
| Net Profit/Loss - EUR | 4.003 | 98.839 | 37.044 | 138.295 | 228.913 | 267.619 | 138.120 | 159.608 | 265.428 | 678.774 |
| Employees | 7 | 8 | 8 | 14 | 21 | 27 | 36 | 38 | 24 | 11 |
Check the financial reports for the company - Pi Pharma M&D S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 75.981 | 79.125 | 139.472 | 213.354 | 400.381 | 871.297 | 812.599 | 610.060 | 555.889 | 455.747 |
| Current Assets | 548.492 | 778.222 | 609.770 | 1.751.493 | 2.721.598 | 3.712.683 | 4.218.437 | 6.918.563 | 10.230.502 | 12.869.668 |
| Inventories | 126.734 | 337.857 | 289.893 | 551.604 | 831.706 | 990.519 | 2.152.842 | 1.888.031 | 2.689.678 | 1.449.991 |
| Receivables | 395.574 | 315.324 | 586.506 | 1.333.522 | 1.786.530 | 2.515.678 | 1.860.264 | 4.718.300 | 7.413.785 | 11.311.273 |
| Cash | 26.183 | 125.042 | -266.630 | -133.633 | 103.361 | 206.487 | 205.332 | 312.232 | 127.039 | 108.404 |
| Shareholders Funds | 101.505 | 99.656 | 113.123 | 198.446 | 290.423 | 552.537 | 664.617 | 826.287 | 1.089.209 | 1.761.895 |
| Social Capital | 90 | 89 | 88 | 10.745 | 10.537 | 62.021 | 60.645 | 202.778 | 404.326 | 402.067 |
| Debts | 522.968 | 757.741 | 636.335 | 1.766.624 | 2.831.610 | 4.033.809 | 4.367.978 | 6.722.754 | 9.714.346 | 11.593.058 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 1.000 | 789 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Pi Pharma M&D S.r.l.